Search Results 1751-1760 of 15589 for Orange Peel tea

1. (VOYAGER) Study Of Avapritinib Vs Regorafenib In Patients With Locally Advanced Unresectable Or Metastatic GIST - Mayo Clinic

   About this study. This is an open-label, randomized, Phase 3 study in patients with locally advanced unresectable or metastatic GIST (advanced GIST) of ...

2. To Compare The Effects Of Immediate-release Tacrolimus And Astagraf XL On Donor-Specific Antibody (DSA) Formation And The Development Of Immune Activation (IA) In De Novo Kidney Transplant Recipients - Mayo Clinic

   About this study. This study will compare the incidence of a two-part composite endpoint consisting of de novo donor specific antibody (DSA) formation or a ...

3. A Study To Assess The Anti-fatigability Effect Of CK-2127107 In Elderly Male And Female Subjects With Limitations In Mobility - Mayo Clinic

   The purpose of this study is to investigate the effect of CK-2127107 versus placebo on skeletal muscle fatigue assessed as change from baseline versus 14 days ...

4. A Randomized, Double-blind, Placebo-controlled Study To Investigate The Efficacy And Safety Of Depemokimab In Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

   A Randomized, Double-blind, Placebo-controlled Study To Investigate The Efficacy And Safety Of Depemokimab In Adults With Hypereosinophilic Syndrome (HES).

5. Defactinib Combined With Pembrolizumab And Gemcitabine In Patients With Advanced Cancer - Mayo Clinic

   About this study. In pancreatic cancer, targeting the tumor microenvironment has become a promising therapeutic strategy. Focal adhesion kinase (FAK) ...

6. A Study Evaluating Effectiveness And Safety Of FFX Versus Combination Of CPI-613 With MFFX In Patients With Metastatic Adenocarcinoma Of The Pancreas - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness and safety of Folfirinox (FFX) versus CPI-613 + Modified Folfirinox (mFFX) in patients with ...

7. Tucatinib And Trastuzumab For Patients With HER2-positive Metastatic Colorectal Cancer - Mayo Clinic

   EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix. Co-morbid systemic illnesses or other severe concurrent disease which, in the ...

8. A Study To Evaluate Gemcitabine And MK-3475 (Pembrolizumab) To Treat Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   Exceptions include basal or squamous cell carcinoma of the skin that has undergone potentially curative therapy or in situ cervical cancer. A history of ...

9. Study To Investigate The Safety And Effectiveness Of Two Doses Of The Antibody Drug GSK2857916 In Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Symptomatic amyloidosis, active 'polyneuropathy, organomegaly, endocrinopathy, myeloma protein, and skin changes' (POEMS) syndrome, active plasma cell ...

10. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment Of Liver Metastases In A Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

    COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment Of Liver Metastases In A Randomized, Double-blind, ...